What You Should Know
- Labcorp launched major digital enhancements to Labcorp Global Trial Connect™, redesigning both the Labcorp Sponsor™ and Labcorp Investigator™ portal experiences.
- Co-developed and guided by direct product testing and feedback from more than 80 biopharma sponsors and 100 clinical investigator sites worldwide.
- Features embedded in-portal kit ordering that cuts manual data entry by 75% while standardizing inventory tracking and supply replenishment.
- Introduces a unified Study Oversight Dashboard that aggregates real-time study progress, site metrics, sample statuses, and supply logistics into a single operational interface.
- Incorporates a guided Report Wizard to simplify custom reporting workflows, alongside end-to-end specimen tracking across the entire sample lifecycle.
Designed with Sponsor and Site Input
The platform updates were built directly on user feedback, product testing, and operational insights gathered from more than 80 biopharma sponsors and 100 clinical investigator sites worldwide.
Key enhancements to the Global Trial Connect ecosystem include:
- 75% Reduction in Kit-Ordering Data Entry: Introduces embedded in-portal collection kit ordering that automates inventory oversight, auto-populates site details, and cuts manual data entry by 75%.
- Unified Study Oversight Dashboard: Consolidates trial metrics, investigator site performance, sample statuses, and logistics supplies into a single operational view.
- End-to-End Sample Tracking: Provides real-time visibility across the entire biospecimen lifecycle—from on-site patient collection through transit, central lab intake, testing, and biobanking.
- Guided Report Wizard: Simplifies data extraction and operational reporting with an intuitive builder designed to generate customized study reports without custom database querying.
- Role-Based Navigation: Delivers a streamlined user interface with role-tailored dashboards and workflows to reduce software onboarding friction for site staff.
“As clinical trials become increasingly complex, sponsors and investigator sites need technology that helps them work more effectively,” said Dr. Brian Caveney, Executive Vice President, President of Biopharma Laboratory Services, and Chief Medical and Scientific Officer at Labcorp. “The latest enhancements to Global Trial Connect make it easier to access insights, manage study activities and navigate trial complexity with confidence, allowing customers to focus less on operational tasks and more on advancing research and supporting patients.”
Labcorp’s central laboratory and trial support footprint spans operations across roughly 100 countries, supporting more than 85% of the new therapeutic drugs approved by the FDA in 2025. The company plans to continue rolling out automated data and logistics features across its Biopharma Laboratory Services portfolio.
